Bayesian Capital Management’s Gildan GIL Stock Holding History

Bayesian Capital Management’s Portfolio GIL Stock Details GIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,307	Closed	-$420K	–	882
2024 Q1	$420K	Buy	+11,307	New	+$384K	0.04%	474
2022 Q4	–	Sell	-9,525	Closed	-$269K	–	859
2022 Q3	$269K	Buy	+9,525	New	+$284K	0.05%	446
2021 Q4	–	Sell	-6,167	Closed	-$225K	–	433
2021 Q3	$225K	Buy	+6,167	New	+$227K	0.07%	327
2019 Q1	–	Sell	-14,963	Closed	-$454K	–	628
2018 Q4	$454K	Sell	14,963 -32,910	-69%	-$1.02M	0.09%	304
2018 Q3	$1.46M	Buy	47,873 +34,300	+253%	+$997K	0.24%	111
2018 Q2	$382K	Buy	+13,573	New	+$394K	0.09%	334
2017 Q3	–	Sell	-8,200	Closed	-$252K	–	534
2017 Q2	$252K	Buy	+8,200	New	+$236K	0.09%	330
2017 Q1	–	Sell	-10,300	Closed	-$261K	–	513
2016 Q4	$261K	Buy	+10,300	New	+$274K	0.06%	462

Other funds holding GIL

JFL

Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return

Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCAM

Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return

CCMIC

Cardinal Capital Management Inc (Canada) Winnipeg, Manitoba, Canada $4.13B AUM 31.23% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Bayesian Capital Management's GIL Position: Q2 2024 in Review

Bayesian Capital Management sold out of Gildan (GIL) in Q2 2024, closing a stake of 11,307 shares — an estimated $420K sold.

Bayesian Capital Management first reported a position in GIL in Q4 2016 and held it in 8 quarters. The position peaked at $1.46M in Q3 2018. 283 funds tracked by Wall St. Rank hold GIL as of Q2 2024.

Bayesian Capital Management reported no remaining Gildan position as of Q2 2024 after selling out during the quarter.
Bayesian Capital Management sold 11,307 Gildan shares in Q2 2024, an estimated $420K.
Bayesian Capital Management first reported a position in Gildan in Q4 2016 and held it in 8 quarters.
Bayesian Capital Management's Gildan position peaked at $1.46M in Q3 2018.
283 funds tracked by Wall St. Rank held Gildan as of Q2 2024.

Based on Bayesian Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.